Verition Fund Management LLC Immatics N.V. Transaction History
Verition Fund Management LLC
- $16.5 Billion
- Q2 2024
A detailed history of Verition Fund Management LLC transactions in Immatics N.V. stock. As of the latest transaction made, Verition Fund Management LLC holds 55,283 shares of IMTX stock, worth $511,367. This represents 0.0% of its overall portfolio holdings.
Number of Shares
55,283Holding current value
$511,367% of portfolio
0.0%Shares
7 transactions
Others Institutions Holding IMTX
# of Institutions
101Shares Held
76.8MCall Options Held
571KPut Options Held
210K-
Rtw Investments, LP New York, NY10MShares$92.5 Million1.94% of portfolio
-
Wellington Management Group LLP Boston, MA9.54MShares$88.2 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$74.8 Million2.72% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.43MShares$68.8 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$59.6 Million1.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $705M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...